Dreman Value Management’s St Jude Medical STJ Stock Holding History

Dreman Value Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-51	Closed	-$4K	–	496
2016 Q3	$4K	Sell	51 -16,862	-100%	-$1.36M	﹤0.01%	400
2016 Q2	$1.32M	Sell	16,913 -616	-4%	-$43.9K	0.82%	41
2016 Q1	$964K	Buy	+17,529	New	+$955K	0.11%	166
2015 Q4	–	Sell	-18,285	Closed	-$1.15M	–	484
2015 Q3	$1.15M	Sell	18,285 -1,099	-6%	-$78.4K	0.12%	167
2015 Q2	$1.42M	Sell	19,384 -9,568	-33%	-$691K	0.12%	198
2015 Q1	$1.89M	Sell	28,952 -1,345	-4%	-$89.4K	0.16%	187
2014 Q4	$1.97M	Sell	30,297 -1,036	-3%	-$66.7K	0.16%	200
2014 Q3	$1.88M	Sell	31,333 -403	-1%	-$26.3K	0.15%	203
2014 Q2	$2.2M	Sell	31,736 -15,466	-33%	-$1M	0.17%	191
2014 Q1	$3.09M	Buy	47,202 +19,713	+72%	+$1.28M	0.24%	161
2013 Q4	$3.02M	Sell	27,489 -22,136	-45%	-$1.28M	0.23%	162
2013 Q3	$2.66M	Buy	+49,625	New	+$2.56M	0.24%	166

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dreman Value Management's STJ Position: Q4 2016 in Review

Dreman Value Management sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 51 shares — an estimated $4K sold.

Dreman Value Management first reported a position in STJ in Q3 2013 and held it in 12 quarters. The position peaked at $3.09M in Q1 2014. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

Dreman Value Management reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
Dreman Value Management sold 51 St Jude Medical shares in Q4 2016, an estimated $4K.
Dreman Value Management first reported a position in St Jude Medical in Q3 2013 and held it in 12 quarters.
Dreman Value Management's St Jude Medical position peaked at $3.09M in Q1 2014.
551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Dreman Value Management's 13F filing for Q4 2016, filed 14 Feb 2017.